AU2015201737B2 - Identification of tumour-associated cell surface antigens for diagnosis and therapy - Google Patents

Identification of tumour-associated cell surface antigens for diagnosis and therapy

Info

Publication number
AU2015201737B2
AU2015201737B2 AU2015201737A AU2015201737A AU2015201737B2 AU 2015201737 B2 AU2015201737 B2 AU 2015201737B2 AU 2015201737 A AU2015201737 A AU 2015201737A AU 2015201737 A AU2015201737 A AU 2015201737A AU 2015201737 B2 AU2015201737 B2 AU 2015201737B2
Authority
AU
Australia
Prior art keywords
nucleic acid
tumour
diagnosis
therapy
identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015201737A
Other versions
AU2015201737A1 (en
Inventor
Gerd Helftenbein
Ugur Sahin
Volker SCHLÜTER
Özlem TÜRECI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biontech SE
Original Assignee
Biontech SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012233057A external-priority patent/AU2012233057B2/en
Application filed by Biontech SE filed Critical Biontech SE
Priority to AU2015201737A priority Critical patent/AU2015201737B2/en
Publication of AU2015201737A1 publication Critical patent/AU2015201737A1/en
Application granted granted Critical
Publication of AU2015201737B2 publication Critical patent/AU2015201737B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides a pharmaceutical composition, comprising an agent which inhibits expression or activity of a tumor-associated antigen, said tumor-associated antigen having a sequence encoded by a nucleic acid which is selected from the group consisting of: (a) a nucleic acid which comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 1, 5, 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57, 61, 65, 69, 73, 77, 81, 85, 89, 93, 97, 101, 105, 109, 113, 117, 121, 125, 129, 133, 137, 141, 145, 149, 153, 157, 161, 165, 169, 173, 175, 179, 183, 187, 191, 195, 199, 203, 207, 211, 215, 219, 223, 227, 231, 235, 239, 243, 247, 251, 255, 259, 263, 267, 269, 271, 273, 275, 277, 279, 309 of the sequence listing, a part or derivative thereof, (b) a nucleic acid which hybridizes with the nucleic acid of (a) under stringent conditions, (c) a nucleic acid which is degenerate with respect to the nucleic acid of (a) or (b), and (d) a nucleic acid which is complementary to the nucleic acid of (a) , (b) or (c).
AU2015201737A 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy Active AU2015201737B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2015201737A AU2015201737B2 (en) 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10344799.7 2003-09-26
AU2012233057A AU2012233057B2 (en) 2003-09-26 2012-09-28 Identification of tumour-associated cell surface antigens for diagnosis and therapy
AU2015201737A AU2015201737B2 (en) 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2012233057A Division AU2012233057B2 (en) 2003-09-26 2012-09-28 Identification of tumour-associated cell surface antigens for diagnosis and therapy

Publications (2)

Publication Number Publication Date
AU2015201737A1 AU2015201737A1 (en) 2015-04-30
AU2015201737B2 true AU2015201737B2 (en) 2016-09-15

Family

ID=53008145

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2015201737A Active AU2015201737B2 (en) 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy
AU2015201738A Active AU2015201738B2 (en) 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2015201738A Active AU2015201738B2 (en) 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy

Country Status (1)

Country Link
AU (2) AU2015201737B2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2478413A1 (en) * 2002-03-13 2003-09-18 Ganymed Pharmaceuticals Ag Genetic products differentially expressed in tumors and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281059A1 (en) * 1997-02-24 1998-08-27 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU2001241541A1 (en) * 2000-02-17 2001-08-27 Millennium Predictive Medicine, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2478413A1 (en) * 2002-03-13 2003-09-18 Ganymed Pharmaceuticals Ag Genetic products differentially expressed in tumors and use thereof

Also Published As

Publication number Publication date
AU2015201738A1 (en) 2015-04-30
AU2015201738B2 (en) 2016-10-13
AU2015201737A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
NZ583028A (en) Nucleic acids and proteins from streptococcus groups A & B
EP2168596A3 (en) Immunisation against chlamydia trachomatis
WO2001070174A3 (en) Vegf-modulated genes and methods employing them
IL145535A0 (en) Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
ITFI920052A1 (en) PROTEIN EXTRACTED FROM HELICOBACTER PYLORI CYTOTOXIC STRAINS, GENE THAT EXPRESSES IT, USE OF PROTEIN AS VACCINE OR DIAGNOSTIC.
WO2000066739A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
WO2002061076A1 (en) Adiponectin-associated protein
IL135688A0 (en) Human checkpoint kinase, hcds1, compositions and methods
NZ526879A (en) Genes and proteins, and their use
WO1998011234A3 (en) Human protein kinases
HU228469B1 (en) Attenuated pestiviruses, their use, and nuclein acids for their production
AU2005203173A1 (en) Super-antigen fusion proteins and the use thereof
WO2001046225A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO1999028439A3 (en) Erythrovirus and its applications
DE60332425D1 (en) 5T4-ANTIGEN-PEPTIDEPITOPES OF MHC CLASS II
AU2015201737B2 (en) Identification of tumour-associated cell surface antigens for diagnosis and therapy
EP2172214A3 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
MXPA01004353A (en) Chlamydia.
WO2000006742A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2004046326A3 (en) Modulation of interleukin 22 receptor expression
PL370854A1 (en) Ee3-protein family and corresponding dna sequences
WO2000026239A3 (en) $i(chlamydia) antigens and corresponding dna fragments and uses thereof
EP1584628A3 (en) Viral protein
WO2000009711A8 (en) ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)